CVE-2017-17844

Description

An issue was discovered in Enigmail before 1.9.9. A remote attacker can obtain cleartext content by sending an encrypted data block (that the attacker cannot directly decrypt) to a victim, and relying on the victim to automatically decrypt that block and then send it back to the attacker as quoted text, aka the TBE-01-005 "replay" issue.

Category

6.5
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.25%
Vendor Advisory debian.org Vendor Advisory enigmail.net
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://enigmail.net/download/other/Enigmail%20Pentest%20Report%20by%20Cure53%20-%20Excerpt.pdf third party advisory vendor advisory
https://lists.debian.org/debian-security-announce/2017/msg00333.html third party advisory
https://www.mail-archive.com/enigmail-users%40enigmail.net/msg04280.html
https://lists.debian.org/debian-lts-announce/2017/12/msg00021.html mailing list
https://www.debian.org/security/2017/dsa-4070 third party advisory vendor advisory

Frequently Asked Questions

What is the severity of CVE-2017-17844?
CVE-2017-17844 has been scored as a medium severity vulnerability.
How to fix CVE-2017-17844?
To fix CVE-2017-17844, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-17844 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-17844 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.